EmployblEmploybl logo
employbl
Evommune logo

Evommune Funding & Investors

Palo Alto, CA

Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines for inflammatory diseases.

evommune.com

Total Amount Raised: $268,000,000

Evommune Funding Rounds

  • Series C

    $115,000,000

    Series C Investors

    RA Capital Management
    Sectoral Asset Management
    Allostery Investments
    Pivotal bioVenture Partners
    ADAR1 Capital Management
    Verition Fund Management
    Amplitude Ventures
    LSP (Life Sciences Partners)
    B Capital
    Andera Partners
    FemHealth Ventures
    SymBiosis
    Avego Bioscience Capital
    Marshall Wace
    Longwood Fund
    RTW Investments
    NEXTBio Capital
    Oscar & Paul

  • Series B

    $7,500,000

    Series B Investors

    Verition Fund Management

  • Series B

    $50,000,000

    Series B Investors

    Arix Bioscience
    LSP (Life Sciences Partners)
    SymBiosis
    Amplitude Ventures
    Andera Partners
    Pivotal bioVenture Partners

  • Series A

    $83,000,000

    Series A Investors

    Pivotal bioVenture Partners
    Andera Partners
    LSP BioVentures

  • Seed

    $12,500,000

    Seed Investors

    Pivotal bioVenture Partners
Funding info provided by Diffbot.